# BCMA-CD19 compound CAR T cells for systemic lupus erythematosus: a phase 1 open-label clinical trial

*PRI Rank #5 · Topics and Trends in Most Cited T-cell and B-cell Immunology Papers, Class of 2026*

*Canonical URL: https://pri.pepkio.com/top-papers/t-cell-and-b-cell-immunology/2026/rank-5*

| Field | Value |
| --- | --- |
| Rank | #5 |
| 18m citations | 119 |
| Journal | Annals of the Rheumatic Diseases |
| Year | 2024 |
| DOI | 10.1136/ard-2024-225785 |
| Corresponding authors | Yong Yuan |
| Institution | Zhongshan City People's Hospital, China |

**Ranking page:** [Topics and Trends in Most Cited T-cell and B-cell Immunology Papers, Class of 2026](https://pri.pepkio.com/top-papers/t-cell-and-b-cell-immunology/2026)

**Paper link:** [10.1136/ard-2024-225785](https://doi.org/10.1136/ard-2024-225785)

## Topics

Dual-target CAR T cells · systemic lupus erythematosus · phase 1 clinical trial · BCMA · CD19 · Dual-target CAR T cells · autoimmune disease · B cell depletion · plasma cell targeting · CAR T cell therapy

## Cite this ranking

```
Pepkio Research Index (PRI). Topics and Trends in Most Cited T-cell and B-cell Immunology Papers, Class of 2026. https://pri.pepkio.com/top-papers/t-cell-and-b-cell-immunology/2026. Accessed 2026-07-21.

Zheng Su, Tinsley Li, Thematic Shifts in Early-High-Impact Cancer Genomics and Diagnostics Research: A Bibliometric and Semantic Analysis. bioRxiv 2026.07.04.736459; doi: https://doi.org/10.64898/2026.07.04.736459
```